SYMLIN Market OpportunityNorth America and Western Europe

Over 32 million people with diabetes in

North America and Western Europe

Source: Amylin internal data

SYMLIN

Target

Population

UsingInsulin

8.2 M

Not Using Insulin

13.4 M

Not Diagnosed

10.5 M

Previous slide

Next slide

Back to first slide

View graphic version